Parallel Advisors’s Prestige Consumer Healthcare PBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $16K | Sell |
339
-608
| -64% | -$31.2K | ﹤0.01% | 2725 |
|
|
2026
Q1 | $56.1K | Buy |
947
+63
| +7% | +$4.09K | ﹤0.01% | 1925 |
|
|
2025
Q4 | $54.5K | Buy |
884
+128
| +17% | +$7.83K | ﹤0.01% | 1803 |
|
|
2025
Q3 | $47.2K | Sell |
756
-3
| -0.4% | -$209 | ﹤0.01% | 1829 |
|
|
2025
Q2 | $60.6K | Buy |
759
+9
| +1% | +$753 | ﹤0.01% | 1614 |
|
|
2025
Q1 | $64.5K | Hold |
750
| – | – | ﹤0.01% | 1495 |
|
|
2024
Q4 | $58.6K | Buy |
750
+39
| +5% | +$3.03K | ﹤0.01% | 1547 |
|
|
2024
Q3 | $51.3K | Buy |
711
+1
| +0.1% | +$71 | ﹤0.01% | 1622 |
|
|
2024
Q2 | $48.9K | Sell |
710
-32
| -4% | -$2.17K | ﹤0.01% | 1535 |
|
|
2024
Q1 | $53.8K | Buy |
742
+28
| +4% | +$1.87K | ﹤0.01% | 1462 |
|
|
2023
Q4 | $43.7K | Buy |
714
+213
| +43% | +$12.6K | ﹤0.01% | 1491 |
|
|
2023
Q3 | $28.7K | Buy |
501
+107
| +27% | +$6.47K | ﹤0.01% | 1670 |
|
|
2023
Q2 | $23.4K | Sell |
394
-282
| -42% | -$16.9K | ﹤0.01% | 1780 |
|
|
2023
Q1 | $42.3K | Buy |
676
+289
| +75% | +$18K | ﹤0.01% | 1458 |
|
|
2022
Q4 | $24.2K | Sell |
387
-5
| -1% | -$287 | ﹤0.01% | 1629 |
|
|
2022
Q3 | $20K | Buy |
392
+20
| +5% | +$1.11K | ﹤0.01% | 1685 |
|
|
2022
Q2 | $22K | Sell |
372
-61
| -14% | -$3.36K | ﹤0.01% | 1629 |
|
|
2022
Q1 | $23K | Sell |
433
-186
| -30% | -$10.7K | ﹤0.01% | 1668 |
|
|
2021
Q4 | $38K | Hold |
619
| – | – | ﹤0.01% | 1478 |
|
|
2021
Q3 | $35K | Buy |
619
+190
| +44% | +$10.4K | ﹤0.01% | 1458 |
|
|
2021
Q2 | $22K | Hold |
429
| – | – | ﹤0.01% | 1634 |
|
|
2021
Q1 | $19K | Buy |
429
+162
| +61% | +$6.81K | ﹤0.01% | 1615 |
|
|
2020
Q4 | $9K | Buy |
267
+106
| +66% | +$3.76K | ﹤0.01% | 1836 |
|
|
2020
Q3 | $6K | Buy |
161
+31
| +24% | +$1.15K | ﹤0.01% | 1958 |
|
|
2020
Q2 | $4K | Buy |
130
+100
| +333% | +$4K | ﹤0.01% | 2023 |
|
|
2020
Q1 | $1K | Hold |
30
| – | – | ﹤0.01% | 2313 |
|
|
2019
Q4 | $1K | Hold |
30
| – | – | ﹤0.01% | 2333 |
|
|
2019
Q3 | $1K | Hold |
30
| – | – | ﹤0.01% | 2306 |
|
|
2019
Q2 | $1K | Hold |
30
| – | – | ﹤0.01% | 2223 |
|
|
2019
Q1 | $1K | Sell |
30
-73
| -71% | -$2.09K | ﹤0.01% | 2205 |
|
|
2018
Q4 | $3K | Sell |
103
-62
| -38% | -$2.26K | ﹤0.01% | 1763 |
|
|
2018
Q3 | $6K | Buy |
165
+62
| +60% | +$2.35K | ﹤0.01% | 1667 |
|
|
2018
Q2 | $3K | Buy |
103
+30
| +41% | +$1.01K | ﹤0.01% | 1756 |
|
|
2018
Q1 | $2K | Buy |
+73
| New | +$2.8K | ﹤0.01% | 1863 |
|
|
2017
Q3 | – | Sell |
-4
| Closed | – | – | 2186 |
|
|
2017
Q2 | $0 | Buy |
+4
| New | +$214 | ﹤0.01% | 2179 |
|
|
2017
Q1 | – | Sell |
-105
| Closed | -$5K | – | 2055 |
|
|
2016
Q4 | $5K | Buy |
+105
| New | +$5.07K | ﹤0.01% | 1373 |
|
Other funds holding PBH
AI
BIP
Parallel Advisors's PBH Position: Q2 2026 in Review
Parallel Advisors reduced its Prestige Consumer Healthcare (PBH) stake by 64% in Q2 2026, selling an estimated $31.2K and leaving 339 shares worth $16K. The position accounts for ﹤0.01% of the portfolio, ranked #2725.
Parallel Advisors first reported a position in PBH in Q4 2016 and has held it in 36 quarters since. The position peaked at $64.5K in Q1 2025. 319 funds tracked by Wall St. Rank hold PBH as of Q2 2026.
- Parallel Advisors held 339 shares of Prestige Consumer Healthcare worth $16K as of Q2 2026.
- Parallel Advisors sold 608 Prestige Consumer Healthcare shares in Q2 2026, an estimated $31.2K.
- Prestige Consumer Healthcare made up ﹤0.01% of Parallel Advisors's portfolio in Q2 2026, its #2725 holding.
- Parallel Advisors first reported a position in Prestige Consumer Healthcare in Q4 2016 and has held it in 36 quarters since.
- Parallel Advisors's Prestige Consumer Healthcare position peaked at $64.5K in Q1 2025.
- 319 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.
Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.